Infectious Diseases

Search for publications

Only original articles, editorials, guidelines.

Serrano-Villar S, López-Huertas MR, Jiménez D, Galera C, Martínez-Sanz J, Moreno E, Muriel A, Gutiérrez F, Busca C, Portilla J, Bisbal O, Iribarren JA, Tejerina F, de Los Santos I, Moreno S.

Long-Term Changes of Inflammatory Biomarkers in Individuals on Suppressive Three-Drug or Two-Drug Antiretroviral Regimens.

Frontiers in immunology 2022. 13: 848630-848630. Number of citations: 3

[doi:10.3389/fimmu.2022.848630]
Manzano M, Talavera-Rodríguez A, Moreno E, Madrid N, Gosalbes MJ, Ron R, Dronda F, Pérez-Molina JA, Lanza VF, Díaz J, Moreno S, Navia B, Serrano-Villar S.

Relationship of Diet to Gut Microbiota and Inflammatory Biomarkers in People with HIV.

Nutrients 2022. 14(6): . Number of citations: 1

[doi:10.3390/nu14061221]
Albóniga OE, Jiménez D, Sánchez-Conde M, Vizcarra P, Ron R, Herrera S, Martínez-Sanz J, Moreno E, Moreno S, Barbas C, Serrano-Villar S.

Metabolic Snapshot of Plasma Samples Reveals New Pathways Implicated in SARS-CoV-2 Pathogenesis.

JOURNAL OF PROTEOME RESEARCH 2022. 21(3): 623-634. Number of citations: 1

[doi:10.1021/acs.jproteome.1c00786]
Sainz T, Diaz L, Rojo D, Clemente MI, Barbas C, Gosalbes MJ, Jimenez-Hernandez N, Escosa L, Guillen S, Ramos JT, Muñoz-Fernández MÁ, Navarro ML, Mellado MJ, Serrano-Villar S.

Targeting the Gut Microbiota of Vertically HIV-Infected Children to Decrease Inflammation and Immunoactivation: A Pilot Clinical Trial

Nutrients 2022. 14(5): . Number of citations: 6

[doi:10.3390/nu14050992]
Podzamczer D, Micán R, Tiraboschi J, Portilla J, Domingo P, Llibre JM, Ribera E, Vivancos MJ, Morano L, Masiá M, Gómez C, Fanjul F, Payeras A, Inciarte A, Estrada V, Rivero A, Castro Á, Bernal E, Vinuesa D, Knobel H, Troya J, Macías J, Montero M, Sanz J, Navarro-Alcaraz A, Caicedo A, Fernández G, Martínez E, Moreno S.

Darunavir/Cobicistat/Emtricitabine/Tenofovir Alafenamide Versus Dolutegravir/Abacavir/Lamivudine in Antiretroviral-Naive Adults (SYMTRI): A Multicenter Randomized Open-Label Study (PReEC/RIS-57)

Open forum infectious diseases 2022. 9(3): .

[doi:10.1093/ofid/ofab595]
Balandín B, Ballesteros D, Pintado V, Soriano-Cuesta C, Cid-Tovar I, Sancho-González M, Pérez-Pedrero MJ, Chicot M, Asensio-Martín MJ, Silva JA, de Luna RR, Gesso CM, Rodríguez-Serrano DA, Martínez-Sagasti F, Royuela A.

Multicentre study of ceftazidime/avibactam for Gram-negative bacteria infections in critically ill patients

INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS 2022. 59(3): 106536-106536. Number of citations: 10

[doi:10.1016/j.ijantimicag.2022.106536]
Sherrill-Mix S, Yang M, Aldrovandi GM, Brenchley JM, Bushman FD, Collman RG, Dandekar S, Klatt NR, Lagenaur LA, Landay AL, Paredes R, Tachedjian G, Turpin JA, Serrano-Villar S, Lozupone CA, Ghosh M.

A Summary of the Sixth International Workshop on Microbiome in HIV Pathogenesis, Prevention, and Treatment

AIDS RESEARCH AND HUMAN RETROVIRUSES 2022. 38(3): 173-180.

[doi:10.1089/aid.2021.0173]
Fursa O, Mocroft A, Lazarus JV, Amele S, Lundgren J, Matulionyte R, Rasmussen LD, Rockstroh JK, Parczewski M, Jilich D, Moreno S, Vassilenko A, Lacombe K, Wandeler G, Borodulina E, Brännström J, Wiese L, Orkin C, Behrens GMN, Mansinho K, Portu JJ, Peters L, EuroSIDA study.

The hepatitis C cascade of care in HIV/hepatitis C virus coinfected individuals in Europe: regional and intra-regional differences

AIDS (London, England) 2022. 36(3): 423-435. Number of citations: 9

[doi:10.1097/QAD.0000000000003112]
Vallejo A, Martín-Hondarza A, Gómez S, Velasco H, Vizcarra P, Haemmerle J, Casado JL.

Cellular Responses to Membrane and Nucleocapsid Viral Proteins Are Also Boosted After SARS-CoV-2 Spike mRNA Vaccination in Individuals With Either Past Infection or Cross-Reactivity

FRONTIERS IN MICROBIOLOGY 2022. 12: 812729-812729. Number of citations: 5

[doi:10.3389/fmicb.2021.812729]
Ruiz-Galiana, Julian, de Lucas Ramos, Pilar, Garcia-Botella, Alejandra, Garcia-Lledo, Alberto, Gomez-Pavon, Javier, Gonzalez del Castillo, Juan, Hernandez-Sampelayo, Teresa, Cruz Martin-Delgado, Mari, Martin Sanchez, Francisco Javier, Martinez-Selles, Manuel, Molero Garcia, Jose Maria, Moreno Guillen, Santiago, Rodriguez-Artalejo, Fernando, Canton, Rafael, Bouza, Emilio.

Persistence and viability of SARS-CoV-2 in primary infection and reinfections

REVISTA ESPANOLA DE QUIMIOTERAPIA 2022. 35(1): 1-6. Number of citations: 3

[doi:10.37201/req/129.2021]
de Lucas Ramos, Pilar, Garcia-Botella, Alejandra, Garcia-Lledo, Alberto, Gomez-Pavon, Javier, Gonzalez del Castillo, Juan, Hernandez-Sampelayo, Teresa, Cruz Martin-Delgado, Mari, Martin Sanchez, Francisco Javier, Martinez-Selles, Manuel, Molero Garcia, Jose Maria, Moreno Guillen, Santiago, Rodriguez-Artalejo, Fernando, Ruiz-Galiana, Julian, Canton, Rafael, Bouza, Emilio.

Actions and attitudes on the immunized patients against SARS-CoV-2

REVISTA ESPANOLA DE QUIMIOTERAPIA 2022. 35(1): 7-15. Number of citations: 1

[doi:10.37201/req/131.2021]
Del Amo J, Polo R, Moreno S, Jarrín I, Hernán MA.

SARS-CoV-2 infection and coronavirus disease 2019 severity in persons with HIV on antiretroviral treatment

AIDS (London, England) 2022. 36(2): 161-168. Number of citations: 17

[doi:10.1097/QAD.0000000000003132]
Sojo-Dorado J, López-Hernández I, Rosso-Fernandez C, Morales IM, Palacios-Baena ZR, Hernández-Torres A, Merino de Lucas E, Escolà-Vergé L, Bereciartua E, García-Vázquez E, Pintado V, Boix-Palop L, Natera-Kindelán C, Sorlí L, Borrell N, Giner-Oncina L, Amador-Prous C, Shaw E, Jover-Saenz A, Molina J, Martínez-Alvarez RM, Dueñas CJ, Calvo-Montes J, Silva JT, Cárdenes MA, Lecuona M, Pomar V, Valiente de Santis L, Yagüe-Guirao G, Lobo-Acosta MA, Merino-Bohórquez V, Pascual A, Rodríguez-Baño J, REIPI-GEIRAS-FOREST group.

Effectiveness of Fosfomycin for the Treatment of Multidrug-Resistant Escherichia coli Bacteremic Urinary Tract Infections: A Randomized Clinical Trial.

Jama Network Open 2022. 5(1): . Number of citations: 8

[doi:10.1001/jamanetworkopen.2021.37277]
Pintado V, Ruiz-Garbajosa P, Escudero R, Gioia F, Herrera S, Vizcarra P, Fortún J, Cobo J, Martín-Dávila P, Morosini MI, Cantón R, Moreno S.

Carbapenemase-producing Enterobacterales infections in COVID-19 patients

INFECTIOUS DISEASES 2022. 54(1): 36-45. Number of citations: 8

[doi:10.1080/23744235.2021.1963471]
Gosalbes MJ, Jimenéz-Hernandéz N, Moreno E, Artacho A, Pons X, Ruíz-Pérez S, Navia B, Estrada V, Manzano M, Talavera-Rodriguez A, Madrid N, Vallejo A, Luna L, Pérez-Molina JA, Moreno S, Serrano-Villar S.

Interactions among the mycobiome, bacteriome, inflammation, and diet in people living with HIV.

Gut Microbes 2022. 14(1): 2089002-2089002. Number of citations: 2

[doi:10.1080/19490976.2022.2089002]
Brañas F, Galindo MJ, Torralba M, Antela A, Vergas J, Ramírez M, Ryan P, Dronda F, Busca C, Machuca I, Bustinduy MJ, Cabello A, Sánchez-Conde M.

Different profiles among older adults with HIV according to their chronological age and the year of HIV diagnosis: The FUNCFRAIL cohort study (GeSIDA 9817)

Plos One 2022. 17(3): . Number of citations: 3

[doi:10.1371/journal.pone.0266191]
Bravo-Gallego LY, Francisco-González L, Vázquez-Pérez Á, García-López Hortelano M, López Vélez R, González-Granado LI, Santos M, Epalza C, Jiménez AB, Cilleruelo MJ, Guillén S, Fernández T, Olabarrieta I, Flores-Chavez M, Ramos Amador JT, González-Tomé MI.

Pediatric Chagas disease in the non-endemic area of Madrid: A fifteen-year review (2004-2018).

PLOS NEGLECTED TROPICAL DISEASES 2022. 16(2): 10232-10232. Number of citations: 1

[doi:10.1371/journal.pntd.0010232]
Casado JL, Moraga E, Vizcarra P, Velasco H, Martín-Hondarza A, Haemmerle J, Gómez S, Quereda C, Vallejo A.

Expansion of CD56^dimCD16^neg NK Cell Subset and Increased Inhibitory KIRs in Hospitalized COVID-19 Patients

VIRUSES-BASEL 2022. 14(1): . Number of citations: 10

[doi:10.3390/v14010046]

Instituto Ramón y Cajal de investigación sanitaria

Central Support Units

Other service and technical units

Infectious Diseases

Search for publications

Long-Term Changes of Inflammatory Biomarkers in Individuals on Suppressive Three-Drug or Two-Drug Antiretroviral Regimens.

Relationship of Diet to Gut Microbiota and Inflammatory Biomarkers in People with HIV.

Metabolic Snapshot of Plasma Samples Reveals New Pathways Implicated in SARS-CoV-2 Pathogenesis.

Targeting the Gut Microbiota of Vertically HIV-Infected Children to Decrease Inflammation and Immunoactivation: A Pilot Clinical Trial

Darunavir/Cobicistat/Emtricitabine/Tenofovir Alafenamide Versus Dolutegravir/Abacavir/Lamivudine in Antiretroviral-Naive Adults (SYMTRI): A Multicenter Randomized Open-Label Study (PReEC/RIS-57)

Multicentre study of ceftazidime/avibactam for Gram-negative bacteria infections in critically ill patients

A Summary of the Sixth International Workshop on Microbiome in HIV Pathogenesis, Prevention, and Treatment

The hepatitis C cascade of care in HIV/hepatitis C virus coinfected individuals in Europe: regional and intra-regional differences

Cellular Responses to Membrane and Nucleocapsid Viral Proteins Are Also Boosted After SARS-CoV-2 Spike mRNA Vaccination in Individuals With Either Past Infection or Cross-Reactivity

Persistence and viability of SARS-CoV-2 in primary infection and reinfections

Actions and attitudes on the immunized patients against SARS-CoV-2

SARS-CoV-2 infection and coronavirus disease 2019 severity in persons with HIV on antiretroviral treatment

Effectiveness of Fosfomycin for the Treatment of Multidrug-Resistant Escherichia coli Bacteremic Urinary Tract Infections: A Randomized Clinical Trial.

Carbapenemase-producing Enterobacterales infections in COVID-19 patients

Interactions among the mycobiome, bacteriome, inflammation, and diet in people living with HIV.

Different profiles among older adults with HIV according to their chronological age and the year of HIV diagnosis: The FUNCFRAIL cohort study (GeSIDA 9817)

Pediatric Chagas disease in the non-endemic area of Madrid: A fifteen-year review (2004-2018).

Expansion of CD56^dimCD16^neg NK Cell Subset and Increased Inhibitory KIRs in Hospitalized COVID-19 Patients

Infectious Diseases

Search for publications

Long-Term Changes of Inflammatory Biomarkers in Individuals on Suppressive Three-Drug or Two-Drug Antiretroviral Regimens.

Relationship of Diet to Gut Microbiota and Inflammatory Biomarkers in People with HIV.

Metabolic Snapshot of Plasma Samples Reveals New Pathways Implicated in SARS-CoV-2 Pathogenesis.

Targeting the Gut Microbiota of Vertically HIV-Infected Children to Decrease Inflammation and Immunoactivation: A Pilot Clinical Trial

Darunavir/Cobicistat/Emtricitabine/Tenofovir Alafenamide Versus Dolutegravir/Abacavir/Lamivudine in Antiretroviral-Naive Adults (SYMTRI): A Multicenter Randomized Open-Label Study (PReEC/RIS-57)

Multicentre study of ceftazidime/avibactam for Gram-negative bacteria infections in critically ill patients

A Summary of the Sixth International Workshop on Microbiome in HIV Pathogenesis, Prevention, and Treatment

The hepatitis C cascade of care in HIV/hepatitis C virus coinfected individuals in Europe: regional and intra-regional differences

Cellular Responses to Membrane and Nucleocapsid Viral Proteins Are Also Boosted After SARS-CoV-2 Spike mRNA Vaccination in Individuals With Either Past Infection or Cross-Reactivity

Persistence and viability of SARS-CoV-2 in primary infection and reinfections

Actions and attitudes on the immunized patients against SARS-CoV-2

SARS-CoV-2 infection and coronavirus disease 2019 severity in persons with HIV on antiretroviral treatment

Effectiveness of Fosfomycin for the Treatment of Multidrug-Resistant Escherichia coli Bacteremic Urinary Tract Infections: A Randomized Clinical Trial.

Carbapenemase-producing Enterobacterales infections in COVID-19 patients

Interactions among the mycobiome, bacteriome, inflammation, and diet in people living with HIV.

Different profiles among older adults with HIV according to their chronological age and the year of HIV diagnosis: The FUNCFRAIL cohort study (GeSIDA 9817)

Pediatric Chagas disease in the non-endemic area of Madrid: A fifteen-year review (2004-2018).

Expansion of CD56dimCD16neg NK Cell Subset and Increased Inhibitory KIRs in Hospitalized COVID-19 Patients

Expansion of CD56^dimCD16^neg NK Cell Subset and Increased Inhibitory KIRs in Hospitalized COVID-19 Patients